Lynx1 Capital Management LP Allakos Inc. Call Options Transaction History
Lynx1 Capital Management LP
- $257 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALLK
# of Institutions
81Shares Held
69.2MCall Options Held
47.3KPut Options Held
1K-
Bvf Inc San Francisco, CA16.6MShares$4.97 Million0.75% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$1.84 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.7MShares$1.71 Million0.3% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$1.08 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$1.03 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $25.4M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...